Buy & Sell Clorox Co (CLX) – Clorox Co Price Today
Aura AI Summary
Key Stats
- $11.58BMarket Cap
- Consumer StaplesSector
- -19.98%3M Drawdown
- $14.88BEnterprise Value
- 5.18%Dividend Yield
- 94 daysTypical Hold Time
Clorox Co (CLX) is currently valued at a market capitalization of $11.58B, with an enterprise value of $14.88B. Over the past 52 weeks, Clorox Co has traded between a low of $86.12 and a high of $131.43, highlighting its annual price range. Over the past three months, Clorox Co has recorded a drawdown of -19.98%, reflecting recent price volatility. Clorox Co offers a dividend yield of 5.18%, with the most recent dividend of $1.24 paid on 22 Apr 26. On average, investors hold Clorox Co for approximately 94 days, indicating typical investor behavior on the platform.
About Clorox Co
With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Most Recent News
ProShares Ultra QQQ ETF (QLD) shows 10,000% return over 20 years but carries high risk in downturns.
The ProShares Ultra QQQ ETF (QLD) has delivered an impressive total return of over 10,000% since its inception more than 20 years ago, highlighting its powerful compounding ability. As a daily leveraged ETF, QLD can generate outsized gains during mar...

New AI-managed ETFs launch, using algorithms for stock picks but with no guaranteed performance.
Three new exchange-traded funds (ETFs) managed by an AI algorithm called BAILA have been registered with the SEC. The flagship fund, trading as HIAI, adjusts stock exposure based on market conditions, aiming to outperform the S&P 500 with 20-40 US st...

QT Imaging aims for growth with NASDAQ uplisting and $39M revenue forecast by 2026
QT Imaging is shifting from survival mode to growth, leveraging minimum order deals and a recent uplisting to NASDAQ. Their QT Scan technology offers advantages over traditional mammograms, with ongoing studies potentially proving its superiority. Th...
